Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 20051 - 20075 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cupric oxide	Approved	MAFK	7975	upregulated	cupric oxide results in increased expression of MAFK mRNA	7p22.3	A21783
Cupric oxide	Approved	MAGOH	4116	upregulated	cupric oxide results in increased expression of MAGOH mRNA	1p32.3	A21783
Cupric oxide	Approved	MAP3K21	84451	downregulated	cupric oxide results in decreased expression of MAP3K21 mRNA	1q42.2	A21783
Cupric oxide	Approved	MCM4	4173	downregulated	cupric oxide results in decreased expression of MCM4 mRNA	8q11.21	A21783
Cupric oxide	Approved	MCM6	4175	downregulated	cupric oxide results in decreased expression of MCM6 mRNA	2q21.3	A21783
Cupric oxide	Approved	MED13	9969	upregulated	cupric oxide results in increased expression of MED13 mRNA	17q23.2	A21783
Cupric oxide	Approved	MED21	9412	upregulated	cupric oxide results in increased expression of MED21 mRNA	12p12	A21783
Cupric oxide	Approved	MELK	9833	downregulated	cupric oxide results in decreased expression of MELK mRNA	9p13.2	A21783
Cupric oxide	Approved	MESDC1	59274	downregulated	cupric oxide results in decreased expression of MESDC1 mRNA	15q25.1	A21783
Cupric oxide	Approved	METTL14	57721	upregulated	cupric oxide results in increased expression of METTL14 mRNA	4q26	A21783
Cupric oxide	Approved	MLXIPL	51085	upregulated	cupric oxide results in increased expression of MLXIPL mRNA	7q11.23	A21783
Cupric oxide	Approved	MOB3B	79817	downregulated	cupric oxide results in decreased expression of MOB3B mRNA	9p21.2	A21783
Cupric oxide	Approved	MSI2	124540	upregulated	cupric oxide results in increased expression of MSI2 mRNA	17q22	A21783
Cupric oxide	Approved	MT1A	4489	upregulated	cupric oxide analog results in increased expression of MT1A mRNA	16q13	A21784
Cupric oxide	Approved	MT1A	4489	upregulated	cupric oxide results in increased expression of MT1A mRNA	16q13	A21783
Cupric oxide	Approved	MT1B	4490	upregulated	cupric oxide results in increased expression of MT1B mRNA	16q13	A21783
Cupric oxide	Approved	MT1E	4493	upregulated	cupric oxide results in increased expression of MT1E mRNA	16q13	A21783
Cupric oxide	Approved	MT1F	4494	upregulated	cupric oxide results in increased expression of MT1F mRNA	16q13	A21783
Cupric oxide	Approved	MT1G	4495	upregulated	cupric oxide results in increased expression of MT1G mRNA	16q13	A21783
Cupric oxide	Approved	MT1H	4496	upregulated	cupric oxide results in increased expression of MT1H mRNA	16q13	A21783
Cupric oxide	Approved	MT1L	4500	upregulated	cupric oxide results in increased expression of MT1L mRNA	16q13	A21783
Cupric oxide	Approved	MT1X	4501	upregulated	cupric oxide results in increased expression of MT1X mRNA	16q13	A21783 A21781
Cupric oxide	Approved	MT2A	4502	upregulated	cupric oxide results in increased expression of MT2A mRNA	16q13	A21783
Cupric oxide	Approved	MTF1	4520	upregulated	cupric oxide results in increased expression of MTF1 mRNA	1p34.3	A21783
Cupric oxide	Approved	MVD	4597	upregulated	cupric oxide results in increased expression of MVD mRNA	16q24.2	A21783

Displaying entries 20051 - 20075 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability